News Follow-Shenzhen Bay Laboratory Pingshan Biopharmaceutical R&D and Transformation Center

2022/05/17

Wang Hongyong, General Manager of Force Life, Visits Pingshan Center

On May 16th, Wang Hongyong, General Manager of Force Life Sciences Co., Ltd., visited Pingshan Center.

2022/05/05

Research Trends | Pingshan Center has synthesized a new generation of chiral bifunctional NHC catalysts

Huang Yong/Chen Jiean's research group further expanded the scope of bonding by using the nitrogen heterocyclic carbene thiourea bifunctional catalyst and realized the first highly enantioselective selenium Michael addition reaction.

2022/05/05

Research Trends | Pingshan Center Proposes a New Method to Improve the Performance of Transistor Biosensors

The research team led by Li Zigang/Yin Feng from Pingshan Center and Associate Professor Zhang Min from Peking University published an article in the internationally renowned journal Carbon, elaborating on a biosensor based on carbon nanotube thin film transistors for high sensitivity detection of unlabeled DNA.

2022/04/22

Teachers Wu Yundong and Li Zigang from Pingshan Center were selected as the top 2% scientists in the world

Academician Wu Yundong, Deputy Director of Shenzhen Bay Laboratory, was selected into the "career influence" list of the world's top 2% scientists in this issue; Academician Wu Yundong, Deputy Director of Shenzhen Bay Laboratory, and Professor Li Zigang, Executive Director of Pingshan Center of Shenzhen Bay Laboratory, were selected into the "Annual Influence" list of the world's top 2% scientists in this issue.

2022/04/22

Exchange and Cooperation - Shenzhen Institute of Computing and Chinese Medicine Zhijun Visits Pingshan Center

On April 19th, the team led by He Zheng, the chief architect of the PIoD Research Office of the Shenzhen Institute of Computational Sciences, and the team led by Zeng Huanxiang, the chief engineer of China National Pharmaceutical Group Zhijun (Shenzhen) Pharmaceutical Co., Ltd., visited the Pingshan Center and had an exchange and discussion.

2022/04/20

Hanyu Pharmaceutical, in collaboration with Shenzhen Bay Laboratory and Pingshan Center, has established the "Peptide Innovation Drug Industry Transformation Joint Innovation Center" to promote the industrialization of achievements

On the afternoon of April 19th, Hanyu Pharmaceutical held a strategic cooperation signing and unveiling ceremony with Shenzhen Bay Laboratory and Shenzhen Bay Laboratory Pingshan Biopharmaceutical R&D and Transformation Center in Shenzhen, jointly establishing the "Peptide Innovative Drug Industry Transformation Joint Innovation Center

2022/04/15

Focus on the development of vaccine industry, safeguard national life and health Pingshan Center and Shenzhen Kangtai Biological Products held exchanges and discussions and reached cooperation consensus

Gan Jianhui, Vice President of Shenzhen Kangtai Biological Products Products Co., Ltd. (hereinafter referred to as "Shenzhen Kangtai Biological Products"), and his delegation visited Pingshan Biomedical R&D and Transformation Center of Shenzhen Bay Laboratory (hereinafter referred to as "Pingshan Center") for exchange and discussion. Li Zigang, Executive Director of Pingshan Center, and platform leaders accompanied the visit and participated in the symposium.

2022/04/07

Unveiling! Shenzhen Bay Laboratory Pingshan Center and Pengcheng Laboratory Shennong Platform Joint Laboratory officially established

I met you as a result of fate.

2022/04/07

Shenzhen Bay Laboratory and Hanyu Pharmaceutical reached a consensus on the establishment of the "Joint Innovation Center for Peptide Innovative Drug Industry Transformation"

On the morning of April 6th, Shenzhen Bay Laboratory and Hanyu Pharmaceutical held an exchange and discussion at Shenzhen Bay Laboratory, and both sides reached a consensus on the establishment of the "Joint Innovation Center for Peptide Innovative Drug Industry Transformation".